Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro.

The two mammalian cardiac myosin heavy chain isoforms, alpha and beta, have 93% amino acid homology, but hearts expressing these myosins exhibit marked differences in their mechanical activities. To further understand the function of these cardiac myosins as molecular motors, we compared the ability of these myosins to hydrolyze ATP and to both translocate actin filaments and generate force in an in vitro motility assay. V1 myosin has twice the actin-activated ATPase activity and three times the actin filament sliding velocity when compared with V3 myosin. In contrast, the force-generating ability of these myosins is quite different when the total force produced by a small population of myosin molecules (> 50) is examined. V1 myosin produces only one half the average cross-bridge force of V3 myosin. With discrete areas of primary structural heterogeneity known to exist between alpha and beta heavy chains, the differences we report in the hydrolytic and mechanical activities of the motors are explored in the context of potential structural and kinetic differences between the V1 and V3 myosins.

[1]  K. Trybus,et al.  Smooth muscle myosin cross-bridge interactions modulate actin filament sliding velocity in vitro , 1990, The Journal of cell biology.

[2]  P. Anderson,et al.  Developmental Changes in the Expression of Rabbit Left Ventricular Troponin T , 1988, Circulation research.

[3]  J. D. Pardee,et al.  [18] Purification of muscle actin , 1982 .

[4]  F. Julian,et al.  Rabbit Papillary Muscle Myosin Isozymes and the Velocity of Muscle Shortening , 1984, Circulation research.

[5]  P. Allen,et al.  Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. , 1991, Circulation research.

[6]  Toshio Yanagida,et al.  Force measurements by micromanipulation of a single actin filament by glass needles , 1988, Nature.

[7]  W. Littler,et al.  Myosin adenosinetriphosphatase activity and light chain subunit composition of human right and left ventricle. , 1980, Cardiovascular research.

[8]  N. Alpert,et al.  Myofibrillar adenosine triphosphatase activity in congestive heart failure. , 1962, The American journal of physiology.

[9]  T. L. Hill,et al.  A cross-bridge model of muscle contraction. , 1978, Progress in biophysics and molecular biology.

[10]  K. Trybus,et al.  The essential light chain is required for full force production by skeletal muscle myosin. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  K. Trybus,et al.  Skeletal muscle myosin light chains are essential for physiological speeds of shortening , 1993, Nature.

[12]  D. Warshaw,et al.  Smooth and skeletal muscle myosin both exhibit low duty cycles at zero load in vitro. , 1993, The Journal of biological chemistry.

[13]  K. Trybus,et al.  Coupling of ATPase activity and motility in smooth muscle myosin is mediated by the regulatory light chain , 1994, The Journal of cell biology.

[14]  D A Winkelmann,et al.  Three-dimensional structure of myosin subfragment-1: a molecular motor. , 1993, Science.

[15]  D. Warshaw,et al.  Smooth and skeletal muscle actin are mechanically indistinguishable in the in vitro motility assay. , 1993, Circulation research.

[16]  T. Yanagida,et al.  Single-molecule analysis of the actomyosin motor using nano-manipulation. , 1994, Biochemical and biophysical research communications.

[17]  D. Warshaw,et al.  Enhanced force generation by smooth muscle myosin in vitro. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  N. Alpert,et al.  Energetics of isometric force development in control and volume-overload human myocardium. Comparison with animal species. , 1991, Circulation research.

[19]  D. Warshaw,et al.  Computer-assisted tracking of actin filament motility. , 1992, Analytical biochemistry.

[20]  J. Spudich,et al.  Enzymatic activities correlate with chimaeric substitutions at the actin-binding face of myosin , 1994, Nature.

[21]  L. Leinwand,et al.  Full-length rat alpha and beta cardiac myosin heavy chain sequences. Comparisons suggest a molecular basis for functional differences. , 1989, Journal of molecular biology.

[22]  A. Huxley.  Muscle structure and theories of contraction. , 1957, Progress in biophysics and biophysical chemistry.

[23]  T. L. Hill,et al.  Cross-bridge model of muscle contraction. Quantitative analysis. , 1980, Biophysical journal.

[24]  J. Gwathmey,et al.  Control of myofilament activation in heart failure , 1993 .

[25]  N. Alpert,et al.  Altered Myosin Isozyme Patterns from Pressure‐ Overloaded and Thyrotoxic Hypertrophied Rabbit Hearts , 1982, Circulation research.

[26]  P. Allen,et al.  Changes in Myofibrillar Content and Mg‐ATPase Activity in Ventricular Tissues From Patients with Heart Failure Caused by Coronary Artery Disease, Cardiomyopathy, or Mitral Valve Insufficiency , 1988, Circulation research.

[27]  N. Alpert,et al.  Purification of cardiac myosin. Application to hypertrophied myocardium. , 1975, Biochimica et biophysica acta.

[28]  J. Spudich,et al.  Single myosin molecule mechanics: piconewton forces and nanometre steps , 1994, Nature.

[29]  H. Taussky,et al.  A microcolorimetric method for the determination of inorganic phosphorus. , 1953, The Journal of biological chemistry.

[30]  H. Huxley.  Sliding filaments and molecular motile systems. , 1990, The Journal of biological chemistry.

[31]  R A Milligan,et al.  Structure of the actin-myosin complex and its implications for muscle contraction. , 1993, Science.

[32]  J. Spudich,et al.  A functional recombinant myosin II lacking a regulatory light chain-binding site. , 1993, Science.

[33]  C. Oakley,et al.  Enzymic analysis of endomyocardial biopsy specimens from patients with cardiomyopathies. , 1977, British heart journal.

[34]  A. Huxley,et al.  Reflections on Muscle , 1981 .